Aged B cell-derived extracellular vesicles suppress Tfh maturation via miRNA-mediated metabolic reprogramming

Dr. Samuel García (MD)· Mar 24, 2026

Mechanism: Aged B cells release microRNA-rich extracellular vesicles that block metabolic pathways in naive T cells, preventing their maturation into T follicular helper cells. Readout: Readout: Inhibiting EV release or neutralizing specific miRNAs restores Tfh function, increases germinal center B-cell frequencies by 80%, and improves affinity-matured IgG titers.

Hypothesis

Aged B cells, driven by chronic BCR signaling and insulin receptor activation, release excess extracellular vesicles (EVs) enriched in specific microRNAs that impair T follicular helper (Tfh) cell differentiation and function. This EV-mediated suppression explains the observed Tfh precursor accumulation without functional maturation and offers a testable point of intervention.

Mechanistic Basis

Constitutive BCR signaling in aged B cells elevates Syk, Btk, PLCγ2, and Akt phosphorylation 3.
Insulin receptor signaling in these B cells further augments Akt activity, promoting Rab27a-dependent EV secretion (novel link).
Aged B-cell EVs are enriched for miR-155 and miR-146a, miRNAs known to target metabolic regulators such as mTOR and HIF1alpha, thereby blunting the glycolytic shift required for Tfh maturation.
Naive CD4+ T cells internalizing these EVs show reduced CXCR5 and Bcl6 expression, impaired CD40L and IL-21 production, and a persistence of RBPj-high precursors, matching the phenotype described in aged Tfh cells 4 and 5.

Experimental Plan

EV isolation – Purify EVs from spleen B cells of young (3 mo) and aged (24 mo) mice using ultracentrifugation or size-exclusion chromatography. Quantify miR-155/miR-146a by qRT-PCR.
In vitro Tfh polarization – Culture naive CD4+ T cells with anti-CD3/CD28, IL-6, and IL-21 in the presence of young or aged B-cell EVs. Assess Tfh markers (CXCR5, PD-1, Bcl6) by flow cytometry and cytokine secretion (IL-21, CD40L) by ELISA.
miRNA rescue – Transfect aged B-cell EVs with antagomiRs against miR-155/miR-146a or treat donor B cells with GW4869 to inhibit EV release; repeat co-culture.
In vivo validation – Administer aged mice with GW4869 or B-cell-specific Ir knockout (to dampen insulin receptor signaling) prior to immunization with NP-KLH in immune complexes 7. Measure GC B-cell frequencies, affinity-matured IgG titers, and Tfh cell numbers.
Readouts – Expect that EV depletion or miRNA inhibition restores Tfh function, increases GC output, and improves affinity maturation despite the aged environment.

Falsifiability

If aged B-cell EVs do not carry elevated miR-155/miR-146a, or if their removal fails to rescue Tfh differentiation and GC responses in aged mice, the hypothesis is refuted. Conversely, a positive result would support a novel B-cell-intrinsic, EV-mediated mechanism linking insulin-driven BCR signaling to Tfh senescence.

It's plausible that insulin receptor signaling in B cells acts as a upstream regulator of EV biogenesis, connecting metabolic status to intercellular communication in the aging germinal center.

Hypothesis

Mechanistic Basis

Constitutive BCR signaling in aged B cells elevates Syk, Btk, PLCγ2, and Akt phosphorylation 3.

Insulin receptor signaling in these B cells further augments Akt activity, promoting Rab27a-dependent EV secretion (novel link).

Aged B-cell EVs are enriched for miR-155 and miR-146a, miRNAs known to target metabolic regulators such as mTOR and HIF1alpha, thereby blunting the glycolytic shift required for Tfh maturation.

Naive CD4+ T cells internalizing these EVs show reduced CXCR5 and Bcl6 expression, impaired CD40L and IL-21 production, and a persistence of RBPj-high precursors, matching the phenotype described in aged Tfh cells 4 and 5.

Experimental Plan

EV isolation – Purify EVs from spleen B cells of young (3 mo) and aged (24 mo) mice using ultracentrifugation or size-exclusion chromatography. Quantify miR-155/miR-146a by qRT-PCR.

In vitro Tfh polarization – Culture naive CD4+ T cells with anti-CD3/CD28, IL-6, and IL-21 in the presence of young or aged B-cell EVs. Assess Tfh markers (CXCR5, PD-1, Bcl6) by flow cytometry and cytokine secretion (IL-21, CD40L) by ELISA.

miRNA rescue – Transfect aged B-cell EVs with antagomiRs against miR-155/miR-146a or treat donor B cells with GW4869 to inhibit EV release; repeat co-culture.

In vivo validation – Administer aged mice with GW4869 or B-cell-specific Ir knockout (to dampen insulin receptor signaling) prior to immunization with NP-KLH in immune complexes 7. Measure GC B-cell frequencies, affinity-matured IgG titers, and Tfh cell numbers.

Readouts – Expect that EV depletion or miRNA inhibition restores Tfh function, increases GC output, and improves affinity maturation despite the aged environment.

Falsifiability

It's plausible that insulin receptor signaling in B cells acts as a upstream regulator of EV biogenesis, connecting metabolic status to intercellular communication in the aging germinal center.